Correlation Between Apellis Pharmaceuticals and Kezar Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Kezar Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Kezar Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Kezar Life Sciences, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Kezar Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Kezar Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Kezar Life.

Diversification Opportunities for Apellis Pharmaceuticals and Kezar Life

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Apellis and Kezar is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Kezar Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kezar Life Sciences and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Kezar Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kezar Life Sciences has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Kezar Life go up and down completely randomly.

Pair Corralation between Apellis Pharmaceuticals and Kezar Life

Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 0.96 times more return on investment than Kezar Life. However, Apellis Pharmaceuticals is 1.04 times less risky than Kezar Life. It trades about 0.01 of its potential returns per unit of risk. Kezar Life Sciences is currently generating about -0.07 per unit of risk. If you would invest  5,036  in Apellis Pharmaceuticals on August 29, 2024 and sell it today you would lose (1,622) from holding Apellis Pharmaceuticals or give up 32.21% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Apellis Pharmaceuticals  vs.  Kezar Life Sciences

 Performance 
       Timeline  
Apellis Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apellis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Kezar Life Sciences 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Kezar Life reported solid returns over the last few months and may actually be approaching a breakup point.

Apellis Pharmaceuticals and Kezar Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apellis Pharmaceuticals and Kezar Life

The main advantage of trading using opposite Apellis Pharmaceuticals and Kezar Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Kezar Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will offset losses from the drop in Kezar Life's long position.
The idea behind Apellis Pharmaceuticals and Kezar Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges